Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands.

Ten Haaf ME, Bax M, Ten Berg JM, Brouwer J, Van't Hof AW, van der Schaaf RJ, Stella PR, Tjon Joe Gin RM, Tonino PA, de Vries AG, Zijlstra F, Boersma E, Appelman Y.

Neth Heart J. 2019 May;27(5):263-271. doi: 10.1007/s12471-019-1271-0.

2.

Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement.

Abawi M, van Gils L, Agostoni P, van Mieghem NM, Kooistra NHM, van Dongen CS, van Jaarsveld RC, de Jaegere PPT, Doevendans PAFM, Stella PR.

Catheter Cardiovasc Interv. 2019 Mar 22. doi: 10.1002/ccd.28175. [Epub ahead of print]

PMID:
30901147
3.

Ex Vivo Pilot Study of Cardiac Magnetic Resonance Velocity Mapping for Quantification of Aortic Regurgitation in a Porcine Model in the Presence of a Transcatheter Heart Valve.

Kooistra NHM, Nijhoff F, Abawi M, Agostoni P, Araya Roos DM, van Tuijl S, Blanken N, Voskuil M, Doevendans PAFM, Stella PR, Leiner T.

J Cardiovasc Transl Res. 2019 Aug;12(4):310-320. doi: 10.1007/s12265-019-09878-1. Epub 2019 Mar 15.

4.

Local Ultrasound-Facilitated Thrombolysis in High-Risk Pulmonary Embolism: First Dutch Experience.

de Winter MA, Hart EA, van den Heuvel DAF, Moelker A, Lely RJ, Kaasjager KAH, Stella PR, Chamuleau SAJ, Kraaijeveld AO, Nijkeuter M.

Cardiovasc Intervent Radiol. 2019 Jul;42(7):962-969. doi: 10.1007/s00270-019-02200-1. Epub 2019 Mar 12.

5.

One-year clinical outcomes of patients treated with polymer-free amphilimus-eluting stents or zotarolimus-eluting stents: A propensity-score adjusted analysis.

Rozemeijer R, van Muiden IG, Koudstaal S, Leenders GE, Timmers L, Rittersma SZ, Kraaijeveld AO, Doevendans PA, Voskuil M, Stella PR.

Catheter Cardiovasc Interv. 2019 Jul 1;94(1):61-69. doi: 10.1002/ccd.28041. Epub 2019 Jan 2.

6.

Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.

Rozemeijer R, Stein M, Voskuil M, van den Bor R, Frambach P, Pereira B, Koudstaal S, Leenders GE, Timmers L, Rittersma SZ, Kraaijeveld AO, Agostoni P, Roes KC, Doevendans PA, Stella PR; ReCre8 Study Investigators.

Circulation. 2019 Jan 2;139(1):67-77. doi: 10.1161/CIRCULATIONAHA.118.037707.

PMID:
30586704
7.

Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.

Abawi M, Pagnesi M, Agostoni P, Chiarito M, van Jaarsveld RC, van Dongen CS, Slooter AJC, Colombo A, Kooistra NHM, Doevendans PAFM, Latib A, Stella PR.

J Am Geriatr Soc. 2018 Dec;66(12):2417-2424. doi: 10.1111/jgs.15600. Epub 2018 Oct 8.

PMID:
30296342
8.

Persistent foramen ovale closure in divers with a history of decompression sickness.

Koopsen R, Stella PR, Thijs KM, Rienks R.

Neth Heart J. 2018 Nov;26(11):535-539. doi: 10.1007/s12471-018-1153-x.

9.

Unravelment of Medtronic Onyx stent during bifurcation stenting using the jailed wire technique; An adverse effect of helical stent structure?

Leenders GE, Liew HB, Stella PR.

Cardiovasc Revasc Med. 2018 Dec;19(8S):58-59. doi: 10.1016/j.carrev.2018.03.016. Epub 2018 Mar 21.

PMID:
30115559
10.

The Tryton® dedicated bifurcation stent: Five-year clinical outcomes.

Green PG, Stella PR, Kumsārs I, Dens J, Sonck J, Bennett J, Bethencourt A, López BR, Dudek D, van Geuns RJ, Ramcharitar S.

Cardiovasc Revasc Med. 2019 Apr;20(4):316-323. doi: 10.1016/j.carrev.2018.06.023. Epub 2018 Jul 4.

PMID:
30037716
11.

Coronary artery treatment with a urea-based paclitaxel-coated balloon: the European-wide FALCON all-comers DCB Registry (FALCON Registry).

Widder JD, Cortese B, Levesque S, Berliner D, Eccleshall S, Graf K, Doutrelant L, Ahmed J, Bressollette E, Zavalloni D, Piraino D, Roguin A, Scheller B, Stella PR, Bauersachs J.

EuroIntervention. 2019 Jul 20;15(4):e382-e388. doi: 10.4244/EIJ-D-18-00261.

12.

Short versus long duration of dual antiplatelet therapy following drug-eluting stents: a meta-analysis of randomised trials.

Rozemeijer R, Voskuil M, Greving JP, Bots ML, Doevendans PA, Stella PR.

Neth Heart J. 2018 May;26(5):242-251. doi: 10.1007/s12471-018-1104-6.

13.

Evaluation of mitral regurgitation by an integrated 2D echocardiographic approach in patients undergoing transcatheter aortic valve replacement.

Jansen R, Wind AM, Cramer MJ, Nijhoff F, Agostoni P, Ramjankhan FZ, Suyker WJ, Stella PR, Chamuleau SAJ.

Int J Cardiovasc Imaging. 2018 Aug;34(8):1193-1204. doi: 10.1007/s10554-018-1328-y. Epub 2018 Mar 10.

PMID:
29524077
14.

Anomalous coronary artery originating from the opposite sinus of Valsalva (ACAOS), fractional flow reserve- and intravascular ultrasound-guided management in adult patients.

Driesen BW, Warmerdam EG, Sieswerda GT, Schoof PH, Meijboom FJ, Haas F, Stella PR, Kraaijeveld AO, Evens FCM, Doevendans PAFM, Krings GJ, van Dijk APJ, Voskuil M.

Catheter Cardiovasc Interv. 2018 Jul;92(1):68-75. doi: 10.1002/ccd.27578. Epub 2018 Mar 9.

PMID:
29521471
15.

Rare device landing zone ruptures after transcatheter aortic valve implantation (TAVI).

van Rijswijk JW, Kraaijeveld AO, Voskuil M, Stella PR, Vink A.

Cardiovasc Pathol. 2018 Mar - Apr;33:70-71. doi: 10.1016/j.carpath.2018.01.006. Epub 2018 Feb 2. No abstract available.

PMID:
29459347
16.

Percutaneous closure of a combined ventricular septal defect and paravalvular regurgitation after transcatheter aortic valve implantation: case report.

Kooistra NHM, Krings GJ, Stella PR, Voskuil M.

Eur Heart J Case Rep. 2018 Feb 21;2(1):yty013. doi: 10.1093/ehjcr/yty013. eCollection 2018 Mar.

17.

First dutch experience of the accurate neo self-expanding supra-annular valve for valve-in-valve transcatheter aortic valve implantation.

Soon KH, Kooistra NHM, Voskuil M, Kraaijeveld AO, Stella PR.

Neth Heart J. 2018 Apr;26(4):219-220. doi: 10.1007/s12471-018-1087-3. No abstract available.

18.

Intracardiac shunts following transcatheter aortic valve implantation: a multicentre study.

Amat-Santos IJ, Rojas P, Stella PR, Nombela-Franco L, Lezáun-Burgui R, Muñoz-García AJ, Serra V, Gutierrez-Ibanes E, Larman M, Rodriguez-Olivares R, Kooistra NHM, Gutiérrez H, San Román JA.

EuroIntervention. 2018 Apr 20;13(17):1995-2002. doi: 10.4244/EIJ-D-17-00737.

19.

Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents: A single-center registry.

Rozemeijer R, Benedetto D, Kraaijeveld AO, Voskuil M, Stein M, Timmers L, Rittersma SZ, Agostoni P, Doevendans PA, Stella PR.

Cardiovasc Revasc Med. 2018 Jul;19(5 Pt A):521-525. doi: 10.1016/j.carrev.2017.10.011. Epub 2017 Oct 26.

PMID:
29137966
20.

Evaluation of Cognitive Function Following Transcatheter Aortic Valve Replacement.

Abawi M, de Vries R, Stella PR, Agostoni P, Boelens DHM, van Jaarsveld RC, van Dongen CS, Doevendans PAFM, Emmelot-Vonk MH.

Heart Lung Circ. 2018 Dec;27(12):1454-1461. doi: 10.1016/j.hlc.2017.10.006. Epub 2017 Oct 20.

PMID:
29097068
21.

Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.

Rozemeijer R, Stein M, Frambach P, Voskuil M, Kraaijeveld AO, Rodríguez-Olivares R, Timmers L, Pereira B, Rittersma SZ, Agostoni P, Doevendans PA, Stella PR.

Catheter Cardiovasc Interv. 2018 Feb 15;91(3):410-416. doi: 10.1002/ccd.27142. Epub 2017 May 22.

PMID:
28544782
22.

Effect of body mass index on clinical outcome and all-cause mortality in patients undergoing transcatheter aortic valve implantation.

Abawi M, Rozemeijer R, Agostoni P, van Jaarsveld RC, van Dongen CS, Voskuil M, Kraaijeveld AO, Doevendans PAFM, Stella PR.

Neth Heart J. 2017 Sep;25(9):498-509. doi: 10.1007/s12471-017-1003-2.

23.

Transcatheter Heart Valve Selection and Permanent Pacemaker Implantation in Patients With Pre-Existent Right Bundle Branch Block.

van Gils L, Tchetche D, Lhermusier T, Abawi M, Dumonteil N, Rodriguez Olivares R, Molina-Martin de Nicolas J, Stella PR, Carrié D, De Jaegere PP, Van Mieghem NM.

J Am Heart Assoc. 2017 Mar 3;6(3). pii: e005028. doi: 10.1161/JAHA.116.005028.

24.

Transthoracic Echocardiography Guided MitraClip Placement Under Conscious Sedation.

Hart EA, Teske AJ, Voskuil M, Stella PR, Chamuleau SA, Kraaijeveld AO.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):e27-e29. doi: 10.1016/j.jcin.2016.11.050. No abstract available.

25.

Rationale and design of the Edwards SAPIEN-3 periprosthetic leakage evaluation versus Medtronic CoreValve in transfemoral aortic valve implantation (ELECT) trial : A randomised comparison of balloon-expandable versus self-expanding transcatheter aortic valve prostheses.

Abawi M, Agostoni P, Kooistra NHM, Samim M, Nijhoff F, Voskuil M, Nathoe H, Doevendans PA, Chamuleau SA, Urgel K, Hendrikse J, Leiner T, Abrahams AC, van der Worp B, Stella PR.

Neth Heart J. 2017 May;25(5):318-329. doi: 10.1007/s12471-016-0934-3.

26.

Haemodynamic and functional consequences of the iatrogenic atrial septal defect following Mitraclip therapy.

Hart EA, Zwart K, Teske AJ, Voskuil M, Stella PR, Chamuleau SA, Kraaijeveld AO.

Neth Heart J. 2017 Feb;25(2):137-142. doi: 10.1007/s12471-016-0928-1. Review.

27.

Percutaneous Device to Narrow the Coronary Sinus: Shifting Paradigm in the Treatment of Refractory Angina? A Review of the Literature.

Benedetto D, Abawi M, Stella PR, Nijhoff F, Lakemeier MD, Kortlandt F, Doevendans PA, Agostoni P.

Front Cardiovasc Med. 2016 Oct 21;3:42. eCollection 2016.

28.

An unexpected huge coronary aneurysm.

Chan YH, Duckers E, Stella PR.

EuroIntervention. 2016 Oct 20;12(9):1175. doi: 10.4244/EIJV12I9A190. No abstract available.

29.

Effect of New Cerebral Ischemic Lesions on the Delirium Occurrence After Transcatheter Aortic Valve Replacement.

Abawi M, Nijhoff F, Agostoni P, de Vries R, Slooter AJC, Emmelot-Vonk MH, Voskuil M, Leiner T, Doevendans PA, Stella PR.

J Am Coll Cardiol. 2016 Sep 27;68(13):1489-1490. doi: 10.1016/j.jacc.2016.06.064. No abstract available.

30.

No benefit of additional treatment with exenatide in patients with an acute myocardial infarction.

Roos ST, Timmers L, Biesbroek PS, Nijveldt R, Kamp O, van Rossum AC, van Hout GP, Stella PR, Doevendans PA, Knaapen P, Velthuis BK, van Royen N, Voskuil M, Nap A, Appelman Y.

Int J Cardiol. 2016 Oct 1;220:809-14. doi: 10.1016/j.ijcard.2016.06.283. Epub 2016 Jun 29.

31.

Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience.

Abawi M, Nijhoff F, Stella PR, Voskuil M, Benedetto D, Doevendans PA, Agostoni P.

Neth Heart J. 2016 Sep;24(9):544-51. doi: 10.1007/s12471-016-0862-2.

32.

Ultrasound-accelerated Thrombolysis in a Sub-massive Pulmonary Embolism.

Rodríguez-Olivares R, Kraaijeveld AO, Stella PR.

Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):53. doi: 10.1016/j.rec.2016.04.004. Epub 2016 May 16. English, Spanish. No abstract available.

PMID:
27198126
33.

TriGuard HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement.

Samim M, van der Worp B, Agostoni P, Hendrikse J, Budde RP, Nijhoff F, Ramjankhan F, Doevendans PA, Stella PR.

Catheter Cardiovasc Interv. 2017 Feb 15;89(3):470-477. doi: 10.1002/ccd.26566. Epub 2016 Apr 28.

PMID:
27121306
34.

Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three-dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial.

Grundeken MJ, Garcia-Garcia HM, Kumsars I, Lesiak M, Kayaert P, Dens J, Stella PR, de Winter RJ, Laak LL, Généreux P, Kaplan AV, Leon MB, Wykrzykowska JJ, Onuma Y, Serruys PW.

Catheter Cardiovasc Interv. 2017 Feb 1;89(2):E53-E63. doi: 10.1002/ccd.26527. Epub 2016 Apr 16.

PMID:
27083384
35.

Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT: Depending on Who Is Implanted and How You Implant.

Rodríguez-Olivares R, Nijhoff F, Stella PR.

Rev Esp Cardiol (Engl Ed). 2016 Apr;69(4):455. doi: 10.1016/j.rec.2015.12.010. Epub 2016 Mar 2. No abstract available.

PMID:
26944350
36.

Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.

Nijenhuis VJ, Bennaghmouch N, Hassell M, Baan J Jr, van Kuijk JP, Agostoni P, van 't Hof A, Kievit PC, Veenstra L, van der Harst P, van den Heuvel AF, den Heijer P, Kelder JC, Deneer VH, van der Kley F, Onorati F, Collet JP, Maisano F, Latib A, Huber K, Stella PR, Ten Berg JM.

Am Heart J. 2016 Mar;173:77-85. doi: 10.1016/j.ahj.2015.11.008. Epub 2015 Dec 1.

PMID:
26920599
37.

Incidence, Predictive Factors, and Effect of Delirium After Transcatheter Aortic Valve Replacement.

Abawi M, Nijhoff F, Agostoni P, Emmelot-Vonk MH, de Vries R, Doevendans PA, Stella PR.

JACC Cardiovasc Interv. 2016 Jan 25;9(2):160-8. doi: 10.1016/j.jcin.2015.09.037.

38.

[Innovative therapies for the treatment of refractory angina: the Reducer, a percutaneous device to narrow the coronary sinus].

Benedetto D, Abawi M, Stella PR, Nijhoff F, Agostoni P.

G Ital Cardiol (Rome). 2015 Nov;16(11):625-9. doi: 10.1714/2066.22432. Italian.

PMID:
26571476
39.

Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.

Nijhoff F, Stella PR, Troost MS, Belkacemi A, Nathoe HM, Voskuil M, Samim M, Doevendans PA, Agostoni P.

Clin Res Cardiol. 2016 May;105(5):401-11. doi: 10.1007/s00392-015-0934-0. Epub 2015 Nov 5.

40.

Elevated mean neutrophil volume represents altered neutrophil composition and reflects damage after myocardial infarction.

van Hout GP, van Solinge WW, Gijsberts CM, Teuben MP, Leliefeld PH, Heeres M, Nijhoff F, de Jong S, Bosch L, de Jager SC, Huisman A, Stella PR, Pasterkamp G, Koenderman LJ, Hoefer IE.

Basic Res Cardiol. 2015 Nov;110(6):58. doi: 10.1007/s00395-015-0513-6. Epub 2015 Oct 14.

41.

Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.

Zimmermann FM, Ferrara A, Johnson NP, van Nunen LX, Escaned J, Albertsson P, Erbel R, Legrand V, Gwon HC, Remkes WS, Stella PR, van Schaardenburgh P, Bech GJ, De Bruyne B, Pijls NH.

Eur Heart J. 2015 Dec 1;36(45):3182-8. doi: 10.1093/eurheartj/ehv452. Epub 2015 Sep 23.

42.

Kounis syndrome with cardiogenic shock during transfemoral transcatheter aortic valve replacement.

Benedetto D, Agostoni P, de Waal E, Stella PR.

Coron Artery Dis. 2015 Dec;26(8):726-7. doi: 10.1097/MCA.0000000000000300. No abstract available.

PMID:
26398150
43.

Outcomes of a dedicated stent in coronary bifurcations with large side branches: A subanalysis of the randomized TRYTON bifurcation study.

Généreux P, Kini A, Lesiak M, Kumsars I, Fontos G, Slagboom T, Ungi I, Metzger DC, Wykrzykowska JJ, Stella PR, Bartorelli AL, Fearon WF, Lefèvre T, Feldman RL, Tarantini G, Bettinger N, Minalu Ayele G, LaSalle L, Francese DP, Onuma Y, Grundeken MJ, Garcia-Garcia HM, Laak LL, Cutlip DE, Kaplan AV, Serruys PW, Leon MB.

Catheter Cardiovasc Interv. 2016 Jun;87(7):1231-41. doi: 10.1002/ccd.26240. Epub 2015 Sep 23.

PMID:
26397982
44.

Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.

Nijhoff F, Agostoni P, Belkacemi A, Nathoe HM, Voskuil M, Samim M, Doevendans PA, Stella PR.

Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S34-44. doi: 10.1002/ccd.26060. Epub 2015 Jun 29.

PMID:
26119971
45.

Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison.

Nijhoff F, Abawi M, Agostoni P, Ramjankhan FZ, Doevendans PA, Stella PR.

Circ Cardiovasc Interv. 2015 Jun;8(6):e002408. doi: 10.1161/CIRCINTERVENTIONS.115.002408.

PMID:
26033967
46.

A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.

Généreux P, Kumsars I, Lesiak M, Kini A, Fontos G, Slagboom T, Ungi I, Metzger DC, Wykrzykowska JJ, Stella PR, Bartorelli AL, Fearon WF, Lefèvre T, Feldman RL, LaSalle L, Francese DP, Onuma Y, Grundeken MJ, Garcia-Garcia HM, Laak LL, Cutlip DE, Kaplan AV, Serruys PW, Leon MB.

J Am Coll Cardiol. 2015 Feb 17;65(6):533-43. doi: 10.1016/j.jacc.2014.11.031.

47.

Silent ischemic brain lesions after transcatheter aortic valve replacement: lesion distribution and predictors.

Samim M, Hendrikse J, van der Worp HB, Agostoni P, Nijhoff F, Doevendans PA, Stella PR.

Clin Res Cardiol. 2015 May;104(5):430-8. doi: 10.1007/s00392-014-0798-8. Epub 2015 Jan 18.

PMID:
25596724
48.

Ultra-thin strut cobalt chromium bare metal stent usage in a complex real-world setting. (SOLSTICE registry).

Suttorp MJ, Stella PR, Dens J, McKenzie JM, Park KS, Frambach P; SOLSTICE investigators.

Neth Heart J. 2015 Feb;23(2):124-9. doi: 10.1007/s12471-014-0629-6.

50.

Clinical validation of a novel software for quantitative analysis of coronary intravascular ultrasound.

Nijhoff F, Van Den Hengel KG, Slots TL, Stella PR, Agostoni P.

Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):393-401. doi: 10.1016/j.carrev.2014.10.005. Epub 2014 Oct 14.

PMID:
25456415

Supplemental Content

Loading ...
Support Center